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The PPARg gene regulates insulin sensitivity and adipogenesis. The Pro12Ala polymorphism of this gene has been related to fat accumulation.
Our aim was to analyse the effects of a 2-year nutritional intervention with Mediterranean-style diets on adiposity in high-cardiovascular risk
patients depending on the Pro12Ala polymorphism of the PPARg gene. The population consisted of a substudy (774 high-risk subjects aged
55–80 years) of the Prevencio´n con Dieta Mediterra´nea (PREDIMED) randomised trial aimed at assessing the effect of the Mediterranean diet
for CVD prevention. There were three nutritional intervention groups: two of them of a Mediterranean-style diet and the third was a control
group advised to follow a conventional low-fat diet. All the participants were genotyped by PCR-restriction fragment length polymorphism
(RFLP). The results showed that carriers of the 12Ala allele allocated to the control group had a statistically significant higher change in waist
circumference (adjusted difference coefficient ¼ 2·37 cm; P¼0·014) compared with wild-type subjects after 2 years of nutritional intervention.
This adverse effect was not observed among 12Ala carriers allocated to both Mediterranean diet groups. In diabetic patients a statistically signifi-
cant interaction between Mediterranean diet and the 12Ala allele regarding waist circumference change was observed (25·85 cm; P¼0·003).
In conclusion, the Mediterranean diet seems to be able to reduce waist circumference in a high-cardiovascular risk population, reversing the
negative effect that the 12Ala allele carriers of the PPARg gene appeared to have. The beneficial effect of this dietary pattern seems to be
higher among type 2 diabetic subjects.
Genetic epidemiology: Waist circumference: Mediterranean diet: PPARg
CVD, the leading cause of death in developed countries(1,2), is
a good example of complex and multifactorial disease caused
by genetic, environmental factors and their interactions(3).
Excess of adiposity is a major risk factor for CVD, especially
when this excess is located in visceral depots(4). The preven-
tion of CVD is currently directed to potential modifiable fac-
tors, such as diet and lifestyle factors. In this sense, adiposity
indexes (waist circumference and body weight) could be
modified by interventions aimed to obtain changes in dietary
pattern.
Since the Mediterranean diet was first defined by Keys &
Grande in 1957(5), it has been postulated as beneficial against
CVD(6,7) and type 2 diabetes(8). Olive oil consumption, which
was the main source of fat (MUFA) in traditional Mediterra-
nean diets, has been widely related to this protective
effect(1,7,9,10). Also, tree nuts (a good source of PUFA) are
an integral part of the Mediterranean food pattern and previous
studies have found a protective association between nut con-
sumption and reduced risk of CVD(11 – 13).
One of the most studied genes linked to interactions with
dietary compounds is the PPARg(14 – 17) that encodes a tran-
scription factor (PPARg2) that controls the expression of
genes involved in adipocyte differentiation, lipid storage and
insulin sensitisation. The effects of the 12Ala allele have
been studied in functional analysis, revealing that the receptor
carrying this allele displays reduced DNA-binding affinity and
impaired transcriptional activity in target genes(18). Therefore
the 12Ala in vivo would be expected to protect against
increased adiposity due to the reduced activity of the receptor.
However, previous studies in human subjects showed that the
12Ala allele was associated with increased adiposity(19 – 21).
These contradictory results in vitro and in vivo might be
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explained by a potential enhancing effect of the anti-lipolytic
action of insulin, which leads to reduced release of NEFA(18).
The Pro12Ala substitution in this gene has also been widely
associated with diabetes(22). Moreover, a positive association
between the 12Ala allele of the PPARg and obesity-related
traits was reported among diabetic patients(23).
Most of the associations between diet, risk factors for
chronic diseases and genetics have come from observational
epidemiological studies and, as with conventional nutrition
research, such observations need to be verified by randomised
dietary intervention trials to provide the strongest evidence of
causality(24). As PPARg is known to be activated by fatty
acids(25), we hypothesised that the effects of a high consump-
tion of virgin olive oil or nuts could be partly explained
by means of the effects mediated by PPARg. Thus, our
aim was to analyse the effects of a 2-year nutritional interven-
tion with Mediterranean-style diets on adiposity in high-
cardiovascular risk patients depending on the Pro12Ala
polymorphism of the PPARg gene.
Research methods and procedures
Study population
The present study has been conducted within the frame of the
Prevencio´n con Dieta Mediterra´nea (PREDIMED) trial. The
design of the PREDIMED trial has been reported in
detail elsewhere(1,26). Briefly, the PREDIMED trial is a
large, parallel-group, multicentre, randomised and controlled
4-year clinical trial that aims to assess the effects of a Medi-
terranean-type diet on CVD and in which participants are
assigned to one of three different dietary patterns (low-fat
diet; Mediterranean diet supplemented with nuts; Mediterra-
nean diet supplemented with virgin olive oil)(1). The study
population is composed of men aged 55–80 years and
women aged 60–80 years with no previously documented
CVD but at high cardiovascular risk. Inclusion criteria were
either diabetes mellitus type 2 or at least three of the follow-
ing risk factors: current smoking, hypertension, hyperlipidae-
mia, HDL-cholesterol ,1·034 mM, overweight or obesity, or
family history of premature CHD.
We included data from 774 participants enrolled in the AP-
UNAV recruitment centre in Pamplona (total number of par-
ticipants was 1055), in which the retention rate during the
second year was greater than 80 %. Of the subjects, 141
were excluded for the present study since we were not able
to obtain DNA samples or their adiposity measures at year 2
were not recorded. All participants provided informed consent
and the protocol was approved by the institutional review
boards of all participating centres according to the Declaration
of Helsinki.
Dietary assessment
The dietary habits of the participants, both at baseline and
after follow-up for 24 months, were assessed using a semi-
quantitative 137-item FFQ previously validated in Spain(27).
More details about the dietary assessment are described
elsewhere(1). We focused the nutritional study on fat intake
changes.
Genotyping
Overnight fasting venous blood samples were collected
in tubes containing EDTA. DNA was extracted from the
buffy coat fraction using a commercial kit (Master PureTM;
Epicentre, Madison, WI, USA). All the subjects were geno-
typed for the Pro12Ala polymorphism of the PPARg
gene (rs1801282) using the PCR-restriction fragment length
polymorphism (RFLP) method as described elsewhere(28).
Statistical analysis
The x2 test was used to evaluate the Hardy–Weinberg equili-
brium. The Kolmogorov–Smirnov test was used to determine
variable distribution. Descriptive analyses of variables
between the three intervention groups were performed using
parametric tests (Student’s t tests; ANOVA followed by
Bonferroni post hoc tests). Means of changes in body weight
and waist circumference were compared among the three
randomised groups and among genotypes using general
Table 1. Baseline characteristics of the participants according to intervention group allocation
(Mean values and standard deviations)
Control (n 197) Virgin olive oil (n 318) Tree nuts (n 258)*
ProPro
(n 168)
12Ala allele
carriers
ProPro
(n 272)
12Ala allele
carriers
ProPro
(n 221)
12Ala allele
carriers
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Sex (% female) 54·8 79·3 52·6 71·7 51·6 45·9
Age (years) 68·0 6·9 71·6 3·9 67·8 6·7 68·7 5·8 67·5 6·8 67·7 5·6
Waist:height 0·6 0·1 0·6 0·1 0·6 0·1 0·6 0·1 0·6 0·1 0·6 0·1
Waist circumference (cm) 95·2 11·6 93·9 9·9 96·6 10·5 93·1 10·4 95·5 9·6 95·8 10·2
Weight (kg) 74·6 12·7 72·6 10·9 76·1 12·2 73·3 10·1 74·9 10·1 75·0 11·1
BMI (kg/m2) 29·1 3·5 29·6 3·1 29·3 3·3 28·8 3·4 29·1 3·1 29·1 3·3
Systolic blood pressure (mmHg) 155·5 20·6 159·3 21·7 155·4 20·4 152·9 22·4 155·7 22·8 156·9 14·4
Diastolic blood pressure (mmHg) 86·2 11·0 85·0 10·0 85·9 10·5 84·7 11·5 87·5 11·1 85·8 11·2
Diabetes (%) 32·1 31·0 34·9 45·7 38·0 40·5
Smoking habit (% current smokers) 17·9 3·4 18·4 6·5 12·7 16·2
* One subject was not included because of missing data for this analysis.
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linear models adjusting for age, baseline BMI (continuous),
sex, diabetes and smoking habit.
The effects of the polymorphism on changes in anthropo-
metric variables were evaluated with multivariate linear
regression models adjusting for relevant variables: age, sex
(males as the reference category), baseline BMI, diabetes
and smoking habits. For each adiposity index (changes in
waist circumference (2nd year waist circumference 2 baseline
waist circumference), body weight (2nd year weight 2
baseline weight) and BMI (2nd year BMI 2 baseline BMI))
three regression models were fit: the first model analysed the
effects of the nutritional intervention and the polymorphism
separately on changes in adiposity indexes. The second
model included the interaction product-term between the
nutritional intervention (olive oil þ nuts v. control) and the
Pro12Ala polymorphism (12Ala carriers v. non-carriers) and
the third model included dummy variables to consider each
possible combination of the genetic variants and the nutri-
tional intervention group simultaneously.
We repeated all these analyses including only diabetic
patients.
Results
Baseline characteristics of the participants, according to the nutri-
tional intervention and the polymorphism, are presented in
Table 1. As expected, because of the randomisation, there were
no statistically significant differences among the three nutritional
groups in any of the biological variables. Most of the PREDIMED
subjects, at baseline, were overweight or obese (91 %) and more
than one-third had a diagnosis of type 2 diabetes.
The analysis of macronutrient intake at the beginning of the
study and after 2 years of nutritional intervention revealed that
the intervention brought about an effective change in the dietary
pattern of the subjects with significant differences in the expected
direction according to the respective allocated group. These
changes were remarkable regarding fat consumption (Table 2).
A significantly higher consumption of total fat, monounsaturated
and polyunsaturated fat (but not saturated fat) was observed in
both Mediterranean diet groups compared with the control
group (Table 2). Moreover, the control group had a significantly
higher ratio of saturated fat:total fat than those subjects allocated
to the Mediterranean diet groups (Table 2).
Table 2. Energy and fat intake after 2 years of nutritional intervention according to intervention group
(Mean values and standard deviations)
Control (n 197) Virgin olive oil (n 318) Tree nuts (n 259)
Mean SD Mean SD Mean SD
Total energy
kJ/d 8024·5 1940·5 9702·3** 1915·4 9780·9*** 1843·1
kcal/d 1917·9 463·8 2318·9** 457·8 2337·7*** 440·5
Total fat (% total energy intake) 34·2 9·8 44·2**** 9·6 44·2**** 9·3
SFA (% total energy intake) 8·9 2·0 9·0 1·7 9·1 1·7
MUFA (% total energy intake) 19·8 4·4 23·4**** 3·6 23·1**** 3·6
PUFA (% total energy intake) 5·6 1·9 6·7**** 1·5 7·1****†† 1·0
MUFA:total fat 0·52 0·05 0·55**** 0·04 0·54****† 0·04
PUFA:total fat 0·15 0·04 0·16* 0·04 0·17****††† 0·02
SFA:total fat 0·24 0·04 0·21**** 0·04 0·21**** 0·04
Mean value was significantly different from that of the control group: *P ¼ 0·009, **P ¼ 0·008, ***P ¼ 0·004, ****P , 0·001.
Mean value was significantly different from that of the virgin olive oil group: †P ¼ 0·019, ††P ¼ 0·001, †††P , 0·001.
Fig. 1. Waist circumference changes according to the Pro12Ala polymorphism ( , ProPro; B, Ala) of the PPARg gene after 2 years of nutritional intervention in
the total population. Data are means, with standard deviation represented by vertical bars. ** Mean value was significantly different from that of the non-mutated
subjects allocated to the control group (P ¼ 0·011).
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To analyse whether the Mediterranean diet had a beneficial
effect on adiposity indexes, we first investigated body weight
and waist circumference changes depending on the inter-
vention group. Mean body weight changes for the control,
olive oil and nuts groups were similar (0·34 (SEM 0·28), 0·33
(SEM 0·22) and 0·87 (SEM 0·21) kg, respectively). The com-
parison for mean body weight changes was not statistically
significant, neither between control and olive oil (P¼0·992)
nor control and nuts (P¼0·131). Mean waist circumference
changes were also alike in the control, olive oil and nuts
groups (0·35 (SEM 0·35), 0·14 (SEM 0·28) and 0·51 (SEM
0·26) cm, respectively). No differences were found when con-
trol and olive oil (P¼0·632) or control and nuts (P¼0·711)
were compared.
The distribution of genotypes for the Pro12Ala of PPARg
gene polymorphism was in Hardy–Weinberg equilibrium in
the study groups, being the 12Ala allele frequency 0·07 in
each group. Due to the low frequency of 12Ala of
the PPARg gene, only four out of the 774 subjects were
homozygous for the polymorphism (Ala12Ala). Therefore
we decided to merge in all the analysis the Ala carriers
(both heterozygous and homozygous merged together as a
single group, representing 14·5 % of the total population)
and to compare them with the non-mutated subjects. Therefore
this variable had always 1 df.
Adjusted mean body weight changes were 0·56 and 0·92 kg
for ProPro and Ala carriers, respectively. Mean waist changes
were 0·30 cm in non-mutated (ProPro) and 1·28 cm in mutated
subjects (Ala carriers), this difference being statistically sig-
nificant (P¼0·046). Moreover, when the three nutritional
groups were also considered in the model, we observed that
in the control group the 12Ala carriers had a significantly
higher (P¼0·011) waist circumference increase compared
with non-carriers after 2 years of nutritional intervention
(Fig. 1). The same tendency was observed when weight
changes were analysed, although the differences within con-
trol subjects carrying the 12Ala allele v. non-mutated subjects
were not statistically significant (data not shown). The poly-
morphism was not associated with differences in waist cir-
cumference changes within both Mediterranean diet groups.
To go deeper in our analysis, several multiple linear
regression models were fitted in order to find out the model
that best predicted the effects of the Mediterranean diet on adi-
posity indexes depending on the Pro12Ala polymorphism of
the PPARg gene. Table 3 shows the model to predict the
effects of the diet (considering the three intervention groups)
and the two groups of genetic variants on waist circumference
changes (2nd year 2 baseline), adjusting for sex, age, baseline
BMI, diabetes and smoking habit. The obtained results sup-
ported the finding of the analysis of covariance (ANCOVA)
showing that carriers of the 12Ala allele had a statistically sig-
nificant increase in waist circumference compared with non-
mutated subjects (ProPro) (P¼0·046). Moreover, we found
that subjects with higher baseline BMI were those with the
highest waist circumference reduction (adjusted changes:
20·20 cm; P,0·001) after 2 years of nutritional intervention
regardless of nutritional intervention and genotype (Table 3).
When a 1 df product-term to assess effect modification (inter-
action) between the nutritional intervention (control (0) v. Med-
iterranean diet groups (1)) and the two groups of genotypes (Ala
carriers (1) v. non-carriers (0)) on waist circumference changes
was introduced in the model (data not shown), the P value was
not statistically significant (B¼21·89; P¼0·095).
Thus, to better analyse the effects of the Mediterranean diet
and the polymorphism together, we applied a multiple
regression model with five dummy variables to include the
combinations of the three nutritional groups and the two
groups of genotypes as compared with non-mutated subjects
(ProPro genotype) allocated to the control group, who were
the single reference category (Table 3). This model was
adjusted for sex, age, baseline BMI, diabetes and smoking
habit and the dependent variable was 2-year waist circumfer-
ence change (2nd year 2 baseline). We found that subjects
allocated to the control group who also were carriers of the
Table 3. Multiple regression models for the analysis of the effects of
the Pro12Ala polymorphism of the PPARg2 gene on waist circumfer-
ence change after 2 years of nutritional intervention
(B coefficients and 95 % confidence intervals)
B* 95 % CI P
Considering the polymorphism and nutritional group main effects
Intercept 7·889 2·815, 12·962 0·002
Age 20·042 20·094, 0·010 0·117
Sex
Males 0 Reference
Females 0·312 20·565, 1·189 0·485
Baseline BMI 20·199 20·301, 20·096 ,0·001
Diabetes
No 0 Reference
Yes 0·187 20·519, 0·893 0·603
Nutritional intervention
Control 0 Reference
Virgin olive oil 20·208 21·055, 0·639 0·630
Nuts 0·146 20·741, 1·032 0·747
Pro12Ala polymorphism
ProPro 0 Reference
12Ala allele carriers 0·980 0·017, 1·942 0·046
Smoking habit
Non-smokers 0 Reference
Ex-smokers 0·388 20·609, 1·386 0·322
Current smokers 0·559 20·547, 1·664 0·217
Introducing five dummy variables to include the combinations of the
three nutritional groups and the two genotype groups†
Intercept 7·965 2·892, 13·038 0·002
Age 20·044 20·096, 0·008 0·096
Sex
Males 0 Reference
Females 0·303 20·574, 1·179 0·498
Baseline BMI 20·201 20·304, 20·098 ,0·001
Diabetes
No 0 Reference
Yes 0·173 20·534, 0·879 0·631
Nutritional intervention and Pro12Ala polymorphism
Control and ProPro 0 Reference
Control and Ala‡ 2·366 0·478, 4·255 0·014
Olive oil and ProPro 0·025 20·889, 0·939 0·957
Olive oil and Ala‡ 0·790 20·783, 2·363 0·324
Nuts and ProPro 0·460 20·497, 1·417 0·346
Nuts and Ala‡ 0·643 21·051, 2·336 0·457
Smoking habit
Non-smokers 0 Reference
Ex-smokers 0·422 20·577, 1·422 0·407
Current smokers 0·607 20·501, 1·714 0·282
* Dependent variable: waist circumference change (2nd year waist circumference 2
baseline waist circumference).
† When the interaction was formally tested, the P value for interaction (2 df; three
diet groups £ two genotype groups) was P ¼ 0·214.
‡ Homozygous and heterozygous subjects merged together in a single group.
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PPARg polymorphism (12Ala) had the highest 2-year waist
circumference increase compared with the reference group
(adjusted difference ¼ 2·37 cm; P¼0·014). In agreement
with the ANCOVA results, there were no statistically signifi-
cant differences within the subjects allocated to the Mediterra-
nean diet groups, independently of the genotype, and the
reference category.
Similar models were fit considering as the dependent vari-
ables body weight or BMI changes. The results were in line
with findings regarding waist circumference, but neither of
them reached significance for the product-terms of interaction
(data not shown).
Of special interest was the analysis that we performed with
the subset of diabetic patients (n 276) in order to investigate
the effects of the Mediterranean diet on adiposity depending
on the genotype for the PPARg within this group. The general
linear model showed that the detrimental effect of the 12Ala
allele on waist changes was statistically significant
(P,0·001) within the subset of diabetic subjects allocated to
the control group (Fig. 2), and the magnitude of this effect
was higher than in the whole population (Figs. 1 and 2). In
diabetic mutated subjects, the Mediterranean diet was able
to reduce waist circumference, reversing the negative effect
of the 12Ala allele (Fig. 2). As shown in the total population
this effect was also observed when analysing body weight
changes although it did not reach statistical significance
(data not shown).
A statistically significant interaction within diabetic subjects
was observed between the nutritional intervention (control (0)
v. Mediterranean diet groups (1)) and the polymorphism (Ala
carriers (1) v. non-carriers (0)) in the multiple linear regression
model. Ala carriers allocated to the Mediterranean diet groups
were predicted to have a statistically significant lower increase
in waist circumference compared with control subjects
(B ¼ 25·85; P¼0·003), although the main effect of the poly-
morphism per se predicted a statistically higher waist circum-
ference change after 2 years of nutritional intervention
(B ¼ 0·980; P¼0·046) (Table 4).
The same models fitted among diabetic patients were per-
formed in non-diabetic patients, but they did not reach statisti-
cal significance (Table 4).
Regarding these results a three-way interaction assessing
genotype (1 df; Ala carriers v. non-carriers) £ intervention
(1 df; control v. Mediterranean diet groups) £ diabetes (1 df;
yes v. no) was tested in our regression model for waist circum-
ference change after 2 years of intervention. We obtained a
non-statistically significant P value (B¼20·66; P¼0·270).
In this context the interaction product diabetes £ genotype
(1 df) resulted statistically significant within the control
group (P¼0·012) when analysing separately the control and
the Mediterranean diet groups (olive oil and nuts merged
together).
Discussion
The excess of adiposity is considered as the main cause of the
increased morbidity and mortality by CVD, especially when
this excess is localised in the abdominal depots(4). Waist cir-
cumference is an excellent marker of abdominal obesity and
consequently of CVD risk(4) and mortality(29). Therefore, the
reduction of adiposity indexes, such as waist circumference
and body weight, would result in an effective prevention for
CVD. We have studied the effect of the Pro12Ala polymorph-
ism of the PPARg gene on 2-year changes in adiposity indexes
in a population assigned to a nutritional intervention trial with
the Mediterranean diet (the PREDIMED trial), a randomised
and controlled study for the prevention of CVD, which
allowed us to control not only for established confounding fac-
tors such as sex, age and baseline parameters but also for
unknown or unmeasured confounders.
First of all, the present results proved the effectiveness of
the Mediterranean diet nutritional intervention since the fat
intake distribution in the three nutritional groups changed in
the expected direction(26). After 2 years, both Mediterranean
dietary groups had a significantly higher consumption of
total fat compared with the control group and the distribution
of fatty acid intake was also very different. The Mediterranean
diet groups had a significantly higher consumption of MUFA
and PUFA and significantly lower saturated fat consumption,
which are important characteristics of the Mediterranean diet-
ary pattern(7).
When we analysed the effects of the nutritional interven-
tion, no differences in changes in waist circumference and
weight were found according to the nutritional group. This
could be explained because the control subjects recruited for
the trial already followed a healthier lifestyle before being
Fig. 2. Waist circumference changes according to the Pro12Ala polymorphism ( , ProPro; B, Ala) of the PPARg gene after 2 years of nutritional intervention in
diabetic patients. Data are means, with standard deviation represented by vertical bars. *** Mean value was significantly different from that of the non-mutated sub-
jects allocated to the control group (P,0·001).
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included in the present study. This fact may justify the small
differences in weight and waist changes between the Mediter-
ranean groups and the control group after 2 years of
intervention.
Our main objective was to analyse the effects of a Mediter-
ranean dietary pattern depending on the Pro12Ala polymorph-
ism of the PPARg gene. We found a minor 12Ala allele
frequency of 0·07, lower than values reported in Spanish
subjects (0·13)(28) but similar to those obtained in European
populations(30).
The analysis of the genotype variants on changes on adi-
posity indexes, adjusted for the nutritional intervention,
revealed that the 12Ala allele was associated with statistically
significant higher increase in waist circumferences (P¼0·046).
It also showed higher, but not significant, body weight
changes and BMI after 2 years of nutritional intervention.
The majority of the studies analysing the effects of the
polymorphism on adiposity indexes are directed to BMI,
but there are few studies analysing the effects of the poly-
morphism on waist circumference. Similarly to our findings,
Pihlajamaki et al. reported a significant association of waist
circumference and the polymorphism in a healthy Finnish
population(31).
When considering the nutritional intervention we observed
that the negative effect of the Ala allele on waist changes
was only present in the control group (P¼0·011) and it was
highly attenuated in the two Mediterranean diet groups
(Fig. 1). It seems that the Mediterranean diet reversed the
Table 4. Multiple regression models for the analysis of the effects of the Pro12Ala polymorphism of the
PPARg2 gene on waist circumference change in diabetic and non-diabetic patients after 2 years of
nutritional intervention
(B coefficients and 95 % confidence intervals)
B* 95 % CI P
Diabetic patients
Main effects of the Pro12Ala polymorphism, adjusted for sex (female), age, baseline BMI, interven-
tion and smoking habit
Pro12Ala polymorphism
Non-mutated 0 Reference
12Ala carriers 0·980 0·017, 1·943 0·046
Considering the interaction product-term nutritional intervention £ polymorphism
Intercept 14·902 5·876, 23·928 0·001
Age 20·131 20·228, 20·034 0·008
Sex
Males 0 Reference
Females 0·111 21·379, 1·601 0·884
Baseline BMI 20·227 20·389, 20·065 0·006
Nutritional intervention
Control 0 Reference
Intervention† 0·396 21·087, 1·879 0·600
Pro12Ala polymorphism
ProPro 0 Reference
12Ala allele carriers 6·272 2·842, 9·702 ,0·001
Intervention† £ 12Ala allele‡ 25·853 29·691, 22·016 0·003
Smoking habit
Non-smokers 0 Reference
Ex-smokers 20·013 21·638, 1·611 0·987
Current smokers 1·126 20·973, 3·226 0·292
Non-diabetic patients
Considering the interaction product-term nutritional intervention £ polymorphism
Intercept 5·491 20·372, 11·353 0·066
Age 20·005 20·067, 0·056 0·862
Sex
Males 0 Reference
Females 0·462 20·620, 1·544 0·402
Baseline BMI 20·199 20·334, 20·064 0·004
Nutritional intervention
Control 0 Reference
Intervention† 0·133 20·874, 1·140 0·795
Pro12Ala polymorphism
ProPro 0 Reference
12Ala allele carriers 0·484 21·766, 2·737 0·672
Intervention† £ 12Ala allele‡ 0·244 22·432, 2·920 0·858
Smoking habit
Non-smokers 0 Reference
Ex-smokers 0·660 20·605, 1·925 0·306
Current smokers 0·310 20·986, 1·606 0·639
* Dependent variable: waist circumference change (2nd year waist circumference 2 baseline waist circumference).
† Intervention refers to the comparison between olive oil and nuts groups v. control group (1 df). The two intervention
groups (olive oil and nuts) were merged together.
‡ 12Ala allele: comparison between 12Ala carriers (homozygotes and heterozygotes merged together) and non-carriers
(ProPro genotype) (1 df).
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detrimental effect that the 12Ala minor allele appears to have
on waist circumference. One plausible hypothesis that could
partly explained this finding is that PPARg gene is known
to be activated by fatty acids(25) and, as stated before, the
Mediterranean diet consists of a high consumption of monoun-
saturated (olive oil) and polyunsaturated fat (nuts).
The interaction between the Mediterranean diet and the
Pro12Ala polymorphism of the PPARg gene on adiposity pre-
sented was not statistically significant (B ¼ 21·863;
P¼0·095) although Robitaille et al. reported a Pro12Ala £
diet interaction on waist circumference: ProPro subjects had
significantly higher waist circumference when higher levels
of total fat (P¼0·007) or saturated fat (P¼0·002) were con-
sumed(2).
Due to the potential role that the Pro12Ala polymorphism of
the PPARg gene seemed to have on type 2 diabetes(22,32), we
performed a specific analysis on diabetic patients. This anal-
ysis revealed that the detrimental effect that the polymorphism
appeared to have on waist circumference and weight changes
was more relevant among these patients than in the total study
population (Fig. 2). Moreover, the reversing effect of the
nutritional intervention was also higher in diabetic 12Ala car-
riers allocated to the two Mediterranean diet groups. The inter-
action product-term, intervention £ 12Ala, was statistically
significant, confirming the protective effect of the Mediterra-
nean diet against higher waist circumference, especially in
12Ala carriers. Some authors have reported the beneficial
effects of the Mediterranean diet on diabetes(8,33,34) and
glycaemic control(35). Likewise, there are also studies analys-
ing the effects of the polymorphism and dietary compounds on
adiposity indexes in diabetic patients. In agreement with our
findings, a higher visceral fat deposition on individuals carry-
ing the 12Ala allele and with a low polyunsaturated fat intake
was reported(23).
Following the present results, it seems that the negative
effect of the 12Ala allele in the total population could be
mostly attributed to diabetic patients. Moreover, we observed
that this effect was only attenuated when these patients fol-
lowed a Mediterranean dietary pattern. This attenuation may
be partly explained by the fact that fatty acids (high intake
of PUFA and MUFA in this dietary pattern) are activating
the PPARg protein and could potentially modify the action
of the Pro12Ala substitution on the receptor activity,
especially in the presence of diabetes(18,23,25).
The present study has several strengths, such as its design,
which is able to provide first-level scientific evidence(36), as
we work in real-life conditions (home-prepared foods). But
the study also has some limitations. The first was to ensure
participants’ compliance with the aid of continuous dietary
instructions. In fact, we could observe that the dietary pattern
(especially fat distribution) was significantly different between
the Mediterranean diet groups and the control group after
2 years of intervention (Table 2). Another limitation of the
statistical procedure is that multiple comparisons were per-
formed in order to examine the contribution of the three nutri-
tional groups and the different genotypes, but the differences
remained statistically significant even after the Bonferroni
correction.
In summary, the present study shows that Mediterranean-
style diets seemed to be able to reduce 2-year waist circumfer-
ence enlargement in a high-cardiovascular risk population,
reversing the negative effect that carrying the 12Ala allele
of the PPARg gene appeared to have. The beneficial effect
of this dietary pattern seemed to be more important among
type 2 diabetic subjects.
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